Summary
Genetic associations with Type 1 (insulin-dependent) diabetes may be primary or secondary to linkage disequilibrium. Studies of different racial groups should allow these to be distinguished. We have reported that Type 1 diabetes is associated with HLA-DR3 and -DR4 in subjects of North Indian (Punjab) origin and now present the results of a study of HLA class II DNA polymorphisms in this group and in white caucasoid subjects. DR4 in North Indian Type 1 diabetic patients was associated with DQβ and DXα DNA polymorphisms identical to those found in DR4-positive white caucasoid patients. This DQβ/DXα pattern was increased in frequency in North Indian diabetic patients vs control subjects (33.3% vs 8.5%,p<0.001, relative risk=5.12 (95% confidence limits: 1.96–13.4)). A DQβ polymorphism with very low relative risk for Type 1 diabetes in white caucasoid subjects was also markedly reduced in North Indian diabetic patients vs control subjects (2.3% vs 24.7%,p<0.02, relative risk = 0.10 (95% confidence limits: 0.02–0.46)). This pattern was associated with DR2 in white caucasoid subjects, but with DRw6 in North Indians. A DR3-associated DRβ polymorphism was markedly increased in North Indian diabetic patients vs control subjects (90.2% vs 40.7%,p<10−6, relative risk = 12.1 (95% confidence limits: 4.32–33.9)). The DQ subregion may be a primary site of genetic influence on susceptibility to Type 1 diabetes. Further studies in different racial groups will clarify the HLA associations of Type 1 diabetes.
Similar content being viewed by others
References
Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, Thomsen M, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M (1981) HLA-D and -DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115
Wolf E, Spencer KM, Cudworth AG (1983) The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetologia 24: 224–230
Tiwari LT, Terasaki PI (1985) In: Tiwari LT, Terasaki PI (eds) HLA and disease associations. Springer, Berlin Heidelberg Tokyo New York, pp 185–210
Baur MP, Neugebauer M, Albert ED (1984) Reference tables of two-locus haplotype frequencies for all MHC marker loci. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility Testing 1984. Springer, Berlin Heidelberg Tokyo New York, pp 677–755
Odugbesan O, Fletcher J, Mijovic C, Mackay E, Bradwell AR, Barnett AH (1987) The HLA-D associations of Type 1 (insulin- dependent) diabetes in Punjabi Asians in the United Kingdom. Diabetologia 30: 618–621
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517
Bidwell JL, Jarrold EA (1986) HLA-DR allogenotyping using ex-on-specific cDNA probes and application of rapid minigel methods. Mol Immunol 23: 1111–1116
Spielman RS, Lee J, Bodmer WF, Bodmer JG, Trowsdale J (1984) Six HLA-D region α chain genes on human chromosome 6: polymorphisms and associations of DCα-related sequences with DR types. Proc Natl Acad Sci USA 81: 3461–3465
Mathews JD (1984) Statistical aspects of immunogenetic associations with disease. In: Simons MJ, Tait BD (eds) Detection of immune-associated genetic markers of human disease. Churchill Livingstone, London, pp 106–136
Owerbach D, Lernmark A, Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J (1983) HLA-D region, β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303: 815–817
Cohen-Haguenauer O, Robbins E, Massart C, Busson M, Deschamps I, Hors J, Lalouel J-M, Dausset J, Cohen D (1985) A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 82: 3335–3339
Festenstein H, Awad J, Hitman GA, Cutbush S, Groves AV, Cassell P, Oilier W, Sachs JA (1986) New HLA DNA polymorphisms associated with autoimmune diseases. Nature 322: 64–67
Bohme J, Carlsson B, Wallin J, Moller E, Persson B, Peterson PA, Rask L (1986) Only one DQ-β restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137: 941–947
Cohen D, Cohen O, Marcadet A, Massart C, Lathrop M, Deschamps I, Hors J, Schuller E, Dausset J (1984) Class II HLA- DCβ-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci USA 81: 1774–1778
Stetler D, Grumet FC, Erlich HA (1985) Polymorphic restriction endonuclease sites linked to the HLA-DRα gene: localization and use as genetic markers of insulin-dependent diabetes. Proc Natl Acad Sci USA 82: 8100–8104
Hitman GA, Sachs J, Cassell P, Awad J, Bottazzo GF, Tarn AC, Schwartz G, Monson JP, Festenstein H (1986) A DR3-related DXα gene polymorphism strongly associates with insulin-dependent diabetes mellitus. Immunogenetics 23: 47–51
Bohme J, Andersson M, Andersson G, Moller E, Peterson PA, Rask L (1985) HLA-DRβ genes vary in number between different DR specificities, whereas the number of DQβ genes is constant. J Immunol 135: 2149–2155
Kohonen-Corish MRJ, Serjeantson SW (1986) RFLP analysis of HLA-DR and -DQ genes and their linkage relationships in the Pacific. Am J Hum Genet 39: 751–762
Arnheim N, Strange C, Erlich H (1985) Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci USA 82: 6970–6974
Serjeantson SW, Kohonen-Corish MRJ, Dunckley H, Reid MA (1986) HLA class II RFLPs are haplotype-specific. Cold Spring Harbor Symp Quant Biol 51 (1): 83–89
Winearls BC, Bodmer JG, Bodmer WF, Bottazzo GF, McNally J, Mann JI, Thorogood M, Smith MA, Baum JD (1984) A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system. Tissue Antigens 24: 234–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, J., Odugbesan, O., Mijovic, C. et al. Class II HLA DNA polymorphisms in Type 1 (insulin-dependent) diabetic patients of North Indian origin. Diabetologia 31, 343–350 (1988). https://doi.org/10.1007/BF02341501
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02341501